期刊文献+

血栓弹力图检测老年高血压患者阿司匹林低反应性及相关因素研究 被引量:2

The Risk Factors Investigation of Aspirin Resistance in old patients with hypertension by Thrombelastography
下载PDF
导出
摘要 目的评价血栓弹力图法(thrombelastography,TEG)对老年高血压患者阿司匹林低反应性(aspirin resistance,AR)的检测价值及相关影响因素,探讨AR与高血压患者血压控制水平的关系。方法选择2008年5月至2010年7月高血压患者340例,男223例,女117例,平均年龄(74.37±7.93)岁,服用阿司匹林(≥75 mg)至少大于1个月。TEG法检测血小板聚集功能并根据检测结果分为AR组和阿司匹林敏感(AS)组;流式细胞仪检测血小板活化指标CD62P、PAC-1水平,同时检测血常规、血生化、同型半胱氨酸、超敏C反应蛋白、B型脑钠肽前体等。结果 TEG法检测AR的发生率为24.12%,其中血压达标组为15.05%,血压不达标组为32.92%,血压不达标组AR的发生率显著升高(χ2=9.688,P=0.002)。与AS组比较,AR组不良心血管事件的发生率增高(63.41%vs 39.15%, 2=-0.216,P=0.003);CD62P水平升高[(21.82±23.05)vs(14.02±19.41),P=0.003];PAC-1水平较高[(49.16±29.32)vs(41.84±28.55),P=0.048];收缩压升高[(147.17±15.36)vs(139.70±16.75),P=0.032];空腹血糖水平升高[(6.54±1.67)vs(5.99±1.30),P=0.002)]。Logistic回归分析显示,收缩压、PAC-1、血糖为AR的独立危险因素。结论TEG法检测老年高血压患者AR发生率较高;AR的高血压患者血压控制水平较差。对于老年高血压患者,应强调积极有效降压同时积极有效使用阿司匹林及控制多种心血管危险因素。 Objective To evaluate the related risk factors for aspirin resistance in elderly patients with hypertension by using thrombelastography. Methods There hundreds and forty elderly patients aged (74.37±7.93)years,who received daily aspirin therapy (1〉 75 mg)for over 1 month,were recruited. Platelet aggregation was measured by thrombelastography platelet mapping assay (TEG). Platelet activation was determined by platelet surface expression of PAC-1 and CD62P after natural activation using flow cytometry. The blood pressure,blood components,blood lipids and glucose were measured. Results (1)24.12% patients were aspirin-resistant. Aspirin resistance was present in 32.92% of the patients with poor blood pressure control,while in 15.05% of the patients with controlled blood pressure(x2=-9.688,P=-0.002). (2)Patients with aspirin resistance had higher recurrent arterial thrombotic events during long-term follow-up than those of patients who were aspirin sensitive (63.41% vs 39.15%, 22=-0.216, P=0.003 ). (3) The systolic pressure, CD62P, PAC-1, fasting blood glucose and triglyceride levels were significantly higher(P〈0.05, respectively)in aspirin-resistant patients. (4)Multivariate analysis revealed that systolic pressure (odds ratio OR 0.980 ;P=0.032), PAC-1 levels (OR 0.980;P=0.001) and fasting blood glucose (OR 0.806;P-0.035)were independent predictors of aspirin resistance. Conclusion The prevalence of aspirin resistance in elderly hypertensive patients is high. Aspirin-resistant patients usually have poor systolic pressure control. It is important to emphasize not only on effective using aspirin but also on optimal blood and other risk factors control.
出处 《中华保健医学杂志》 2012年第3期181-184,共4页 Chinese Journal of Health Care and Medicine
基金 军队"十一五"保健课题(07BJZ01) 国家科技支撑计划课题(2009BA186bB04)
关键词 高血压 老年 阿司匹林低反应性 血栓弹力图 危险因素 血压控制 Hypertension Old people Aspirin resistance Thrombelastograrhy Risk factors Blood control
  • 相关文献

参考文献2

二级参考文献110

  • 1张妍,梁静,周玉杰,袁慧,张永志,董磊.服用阿司匹林后血小板聚集功能对介入治疗后心肌坏死指标的影响[J].中华心血管病杂志,2005,33(8):695-699. 被引量:8
  • 2Anonymous.Collaborative overview of randomized trials of antiplatelet therapy-Ⅰ-Ⅲ[J].BMJ,1994,308(6921-6923):81106,159-168,235-246.
  • 3Helgason C M,Bolin K M,Hoff J A,et al.Development of aspirin resistance in persons with previous ischemic stroke[J].Stroke,1994,25:2331-2336.
  • 4Pappas J M,Westengard J C,Bull B S.Population variability in the effect of aspirin on platelet function:implication for clinical trials and therapy[J].Arch Pathol Lab Med,1994,118:801-804.
  • 5Grotemeyer K H,Scharafinski H W,Husstedt I W.Two-year follow-up of aspirin responder and aspirin non-responder:a pilot-study including 180 post-stroke patients[J].Thromb Res,1993,71:397-403.
  • 6Gum P A,Kotike-Marchant K,Poggio E D,et al.Profile and prevalence of aspirin resistance in patients with cardiovascular disease[J].Am J Cardiol,2001,88:230-235.
  • 7Gum P A,Kottke-Marchant K,Welsh P A,et al.A Prospective,blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease[J].J Am Coll Cardiol,2003,41:961-965.
  • 8Lee P Y,Chen W H,Ng W,et al.Low-dose aspirin increases aspirin resistance in patients with coronary artery disease[J].Am J Med,2005,118:723-727.
  • 9Valles J,Santos M T,Aznar J,et al.Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality:the effect of low-does is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity[J].Circulation,1998,97:350-355.
  • 10Patrono C.Prevention of myocardial infarction and stroke by aspirin:different mechanisms? Different dosage[J]?Thromb Res,1998,92:s7s12.

共引文献39

同被引文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部